We retain a BUY and our multiple to 15x FY23E to arrive at a target price of Rs 1,440/share (15% upside) on the back of the CV recovery cycle, new products, and cost rationalisation.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.